NCT07095816

Brief Summary

Pain is the predominant subjective symptom experienced during the perioperative period in pediatric patients with solid tumors. Intense pain may impede early postoperative activities and delay the recovery process. Preemptive analgesia,as a component of multimodal analgesia strategies,aims to mitigate pain by administering analgesic interventions prior to the application of a noxious stimulus. This approach seeks to diminish both peripheral and central sensitization to pain,thereby alleviating postoperative pain. Currently,while preoperative acetaminophen is widely used in adult surgeries,research is limited for its use in pediatrics. This study aims to evaluate the impact of preemptive acetaminophen on reducing postoperative pain in children with solid tumors under the mode of ERAS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
182

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 27, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 31, 2025

Completed
Last Updated

July 31, 2025

Status Verified

July 1, 2025

Enrollment Period

1.8 years

First QC Date

July 13, 2025

Last Update Submit

July 30, 2025

Conditions

Outcome Measures

Primary Outcomes (12)

  • Using FLACC scale to assess the pain level at 1 hour after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 1 hour after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    1 hour after postoperative awakening

  • Using FLACC scale to assess the pain level at 3 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 3 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    3 hours after postoperative awakening

  • Using FLACC scale to assess the pain level at 6 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 6 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    6 hours after postoperative awakening

  • Using FLACC scale to assess the pain level at 12 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 12 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    12 hours after postoperative awakening

  • Using FLACC scale to assess the pain level at 24 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 24 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    24 hours after postoperative awakening

  • Using FLACC scale to assess the pain level at 48 hours after postoperative awakening

    The FLACC (Face, Legs, Activity, Cry, Consolability) scale score was assessed 48 hours after children aged 1 month to 6 years woke up. It evaluates five items: facial expression, leg movement, activity, crying, and consolability, each scored from 0 to 2. Total scores range from 0 to 10, with higher scores indicating greater pain: 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    48 hours after postoperative awakening

  • Using NRS scale to assess the pain level at 1 hour after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 1 hour after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    1 hour after postoperative awakening

  • Using NRS scale to assess the pain level at 3 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 3 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    3 hours after postoperative awakening

  • Using NRS scale to assess the pain level at 6 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 6 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    6 hours after postoperative awakening

  • Using NRS scale to assess the pain level at 12 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 12 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    12 hours after postoperative awakening

  • Using NRS scale to assess the pain level at 24 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 24 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    24 hours after postoperative awakening

  • Using NRS scale to assess the pain level at 48 hours after postoperative awakening

    The NRS (Numerical Rating Scale) pain score was assessed 48 hours after children aged 6 years and above woke up. Total scores range from 0 (no pain) to 10 (most severe pain). Scores are categorized as 1-3 for mild, 4-6 for moderate, and 7-10 for severe pain.

    48 hours after postoperative awakening

Secondary Outcomes (15)

  • The number of patient-controlled analgesia (PCA) pump activations

    during the first 48 postoperative hours

  • Serum Alanine Aminotransferase (ALT) Concentration

    24 hours after surgery

  • Serum Aspartate Aminotransferase (AST) Concentration

    24 hours after surgery

  • Serum Urea Concentration

    24 hours after surgery

  • Plasma Creatinine Concentration

    24 hours after surgery

  • +10 more secondary outcomes

Study Arms (2)

Acetaminophen(APAP)

EXPERIMENTAL

The experimental group received oral acetaminophen(10 mg/kg)two hours prior to surgery.

Drug: Acetaminophen

sterilized water

PLACEBO COMPARATOR

The placebo group received 10 mg/kg sterilized water two hours prior to surgery.

Drug: Sterilized water

Interventions

A prospective randomized controlled trial was conducted involving pediatric patients with solid tumors. Participants who met the inclusion criteria were randomly assigned using a computer-generated random number table. The APAP group was administered acetaminophen orally at a dose of 10 mg/kg body weight 2 hours before the surgical procedure.

Acetaminophen(APAP)

The placebo group was administered 10 mg/kg of sterile water orally two hours before the surgical procedure.

sterilized water

Eligibility Criteria

Age1 Month - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Informed Consent: Written informed consent was obtained from the parents or legal guardians of all pediatric participants.
  • Age Requirement: Patients aged \>1 month (infants and children) were eligible for enrollment.
  • Diagnosis \& Treatment:
  • Radiologically or pathologically confirmed solid tumors. Ⅱ.Scheduled to undergo tumor resection surgery in the Department of Pediatric Surgical Oncology, Children's Hospital Affiliated to Nanjing Medical University.

You may not qualify if:

  • Lack of Informed Consent: Parental/guardian informed consent was not obtained. ②Allergy/Intolerance: Known hypersensitivity or contraindication to acetaminophen (paracetamol).
  • Hepatic Impairment:Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels \>3× the upper limit of normal (ULN).
  • Renal Dysfunction:Serum urea or creatinine levels exceeding the ULN. ⑤Recent Analgesic Use: Administration of any analgesic medication within 12 hours preoperatively.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Nanjing Medical University

Nanjing, Jiangsu, 210008, China

Location

MeSH Terms

Conditions

Pain, PostoperativeNeoplasms

Interventions

Acetaminophen

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Weibing Tang

    Children's Hospital of Nanjing Medical University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Department of neonatal surgery

Study Record Dates

First Submitted

July 13, 2025

First Posted

July 31, 2025

Study Start

May 15, 2023

Primary Completion

February 27, 2025

Study Completion

March 30, 2025

Last Updated

July 31, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (including demographic, clinical, and outcome variables) collected during the trial will be made available to qualified researchers.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Data will become accessible:Starting Date: 6 months after study completion;End Date: Minimum 5 years after publication
Access Criteria
Access to IPD requires submitting a formal research proposal (including hypothesis/analysis plan, ethical approval proof if applicable, and conflict of interest disclosure) to the investigator's email, along with a signed Data Use Agreement (DUA) prohibiting re-identification, commercial use, and redistribution.

Locations